sb 239063 has been researched along with Hemorrhagic Shock in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, KY | 1 |
| Yu, XY | 1 |
| Bai, YS | 1 |
| Zhu, SH | 1 |
| Tang, HT | 1 |
| Ben, DF | 1 |
| Xiao, SC | 1 |
| Wang, GY | 1 |
| Ma, B | 1 |
| Xia, ZF | 1 |
1 other study available for sb 239063 and Hemorrhagic Shock
| Article | Year |
|---|---|
Role of inhibition of p38 mitogen-activated protein kinase in liver dysfunction after hemorrhagic shock and resuscitation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Imidazoles; Interleukin-1beta; Liver; Ma | 2012 |